Antibody Purification Services Market Size

Antibody Purification Services Market size is expected to reach a USD 3 Billion by the end of 2036, growing at a CAGR of 12% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of antibody purification services was USD 1 Billion. The increasing number of cases of chronic diseases across the world will exponentially help the market to grow in the expected CAGR. WHO stated that even though the overall health problem is in a better place now, the rising burden of non-communicable diseases (NCDs) may impact massively on the world. If current trends of chronic diseases continue, by approximately 2050, chronic illnesses like cancer, diabetes, cardiovascular disease, and respiratory disorders will be responsible for 86% i.e. around 90 million deaths annually; this represents a startling 90% increase in absolute numbers since 2019.

Another reason to propel the antibody purification services market by the end of 2036 is the rising use of therapeutics to treat diseases globally. Presently, almost 4,000 uncommon diseases are not cured appropriately, and only 10% of rare diseases worldwide are treated appropriately. In China, where there are more than 1.4 billion people, there is a strong social need for drug research and solutions for rare diseases despite the low prevalence of these conditions. For instance, in modern medicine, gene therapy is at the forefront. These cutting-edge technologies have the potential to create one-time, permanent cures for infectious and non-communicable diseases (including HIV and sickle cell disease), which afflict tens of millions of people worldwide, the majority of whom reside in low- and middle-income countries (LMICs), by precisely altering the human genome. Although the gene therapy field is still in its infancy, significant funding and early clinical achievements have given it a lot of momentum.